Quarterly report [Sections 13 or 15(d)]

Investments

v3.26.1
Investments
6 Months Ended
Jun. 27, 2026
Investments, Debt and Equity Securities [Abstract]  
Investments
Note 8 : Investments
Short-term Investments
Short-term investments include marketable debt investments in corporate debt, government debt, and financial institution instruments, and are recorded within cash and cash equivalents and short-term investments on the Consolidated Condensed Balance Sheets. Government debt includes instruments such as non-U.S. government bills and bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as fixed- and floating-rate bonds, money market fund deposits, and time deposits. As of June 27, 2026 and December 27, 2025, a substantial majority of time deposits were issued by institutions outside the U.S.
The fair value of our economically hedged marketable debt investments was $13.2 billion as of June 27, 2026 ($21.8 billion as of December 27, 2025). For economically hedged investments still held at the reporting date, we recorded net losses of $95 million in the second quarter of 2026 and net losses of $249 million in the first six months of 2026 (net gains of $329 million in the second quarter of 2025 and net gains of $491 million in the first six months of 2025).
Our remaining unhedged marketable debt investments are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss). The adjusted cost of our unhedged investments was $8.9 billion as of June 27, 2026 ($10.6 billion as of December 27, 2025), which approximated the fair value at each date.
The fair value of marketable debt investments, by contractual maturity, as of June 27, 2026, was as follows:
(In Millions) Fair Value
Due in 1 year or less $ 6,723 
Due in 1–2 years 2,723 
Due in 2–5 years 7,629 
Due after 5 years 1,848 
Instruments not due at a single maturity date1
3,240 
Total $ 22,163 
1 Instruments not due at a single maturity date is composed of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.
Equity Investments
(In Millions) Jun 27, 2026 Dec 27, 2025
Marketable equity investments1
$ 250  $ 484 
Non-marketable equity investments 8,160  8,028 
Total $ 8,410  $ 8,512 
1 A significant portion of our marketable equity investments are subject to contractual or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments.
The components of gains (losses) on equity investments, net for each period were as follows:
  Three Months Ended Six Months Ended
(In Millions) Jun 27, 2026 Jun 28, 2025 Jun 27, 2026 Jun 28, 2025
Unrealized gains (losses) on marketable equity investments, net $ (60) $ (58) $ (216) $ (350)
Unrealized gains (losses) on non-marketable equity investments, net1
10  473  112  473 
Impairment charges on non-marketable equity investments (92) (51) (154) (156)
Unrealized gains (losses) on equity investments, net (142) 364  (258) (33)
Realized gains (losses) on sales of equity investments, net 103  138  147  423 
Gains (losses) on equity investments, net $ (39) $ 502  $ (111) $ 390 
1 Unrealized gains (losses) on non-marketable investments includes observable price adjustments and our share of equity method investee gains (losses) and certain distributions.
In the second quarter of 2025, we recognized upward observable price adjustments of $469 million within gains (losses) on equity investments, net, of which $396 million related to a single investee.
Altera
In the third quarter of 2025, we closed the sale of Altera and retained a 49% interest in the business (refer to "Note 9: Acquisitions and Divestitures" within Notes to Consolidated Condensed Financial Statements). The carrying value of our non-marketable equity investment in Altera is classified within equity investments in the Consolidated Condensed Balance Sheets and was $3.2 billion as of June 27, 2026 and December 27, 2025.
We provide semiconductor wafer manufacturing services to Altera, a related party, in accordance with a wafer manufacturing and sale agreement, for which we recognized revenue of $181 million in the second quarter of 2026 and $320 million in the first six months of 2026. Additionally, and in connection with the divestiture, we have been and will be reimbursed for costs that we incur on behalf of Altera for certain corporate services delivered under a transition services agreement, which may include information technology, finance, supply chain, and other services provided on an interim basis. The majority of such corporate transition services ceased as of March 28, 2026.